Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research group

10.1200/JCO.2011.41.2395

Saved in:

Bibliographic Details
Main Authors:	Yeo, W., Chung, H.C., Chan, S.L., Wang, L.Z., Lim, R., Picus, J., Boyer, M., Mo, F.K.F., Koh, J., Rha, S.Y., Hui, E.P., Jeung, H.C., Roh, J.K., Yu, S.C.H., To, K.F., Tao, Q., Ma, B.B., Chan, A.W.H., Tong, J.H.M., Erlichman, C., Chan, A.T.C., Goh, B.C.
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/115095
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-115095
record_format	dspace
spelling	sg-nus-scholar.10635-1150952023-10-27T07:42:04Z Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research group Yeo, W. Chung, H.C. Chan, S.L. Wang, L.Z. Lim, R. Picus, J. Boyer, M. Mo, F.K.F. Koh, J. Rha, S.Y. Hui, E.P. Jeung, H.C. Roh, J.K. Yu, S.C.H. To, K.F. Tao, Q. Ma, B.B. Chan, A.W.H. Tong, J.H.M. Erlichman, C. Chan, A.T.C. Goh, B.C. CANCER SCIENCE INSTITUTE OF SINGAPORE 10.1200/JCO.2011.41.2395 Journal of Clinical Oncology 30 27 3361-3367 JCOND 2014-12-12T07:11:01Z 2014-12-12T07:11:01Z 2012-09-20 Article Yeo, W., Chung, H.C., Chan, S.L., Wang, L.Z., Lim, R., Picus, J., Boyer, M., Mo, F.K.F., Koh, J., Rha, S.Y., Hui, E.P., Jeung, H.C., Roh, J.K., Yu, S.C.H., To, K.F., Tao, Q., Ma, B.B., Chan, A.W.H., Tong, J.H.M., Erlichman, C., Chan, A.T.C., Goh, B.C. (2012-09-20). Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research group. Journal of Clinical Oncology 30 (27) : 3361-3367. ScholarBank@NUS Repository. https://doi.org/10.1200/JCO.2011.41.2395 0732183X http://scholarbank.nus.edu.sg/handle/10635/115095 000309057800014 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
description	10.1200/JCO.2011.41.2395
author2	CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet	CANCER SCIENCE INSTITUTE OF SINGAPORE Yeo, W. Chung, H.C. Chan, S.L. Wang, L.Z. Lim, R. Picus, J. Boyer, M. Mo, F.K.F. Koh, J. Rha, S.Y. Hui, E.P. Jeung, H.C. Roh, J.K. Yu, S.C.H. To, K.F. Tao, Q. Ma, B.B. Chan, A.W.H. Tong, J.H.M. Erlichman, C. Chan, A.T.C. Goh, B.C.
format	Article
author	Yeo, W. Chung, H.C. Chan, S.L. Wang, L.Z. Lim, R. Picus, J. Boyer, M. Mo, F.K.F. Koh, J. Rha, S.Y. Hui, E.P. Jeung, H.C. Roh, J.K. Yu, S.C.H. To, K.F. Tao, Q. Ma, B.B. Chan, A.W.H. Tong, J.H.M. Erlichman, C. Chan, A.T.C. Goh, B.C.
spellingShingle	Yeo, W. Chung, H.C. Chan, S.L. Wang, L.Z. Lim, R. Picus, J. Boyer, M. Mo, F.K.F. Koh, J. Rha, S.Y. Hui, E.P. Jeung, H.C. Roh, J.K. Yu, S.C.H. To, K.F. Tao, Q. Ma, B.B. Chan, A.W.H. Tong, J.H.M. Erlichman, C. Chan, A.T.C. Goh, B.C. Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research group
author_sort	Yeo, W.
title	Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research group
title_short	Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research group
title_full	Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research group
title_fullStr	Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research group
title_full_unstemmed	Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research group
title_sort	epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase i/ii study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase ii consortium and the cancer therapeutics research group
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/115095
_version_	1781789343485001728

Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research group

Similar Items